Farmaceutica REMEDIA S.A. (BVB:RMAH)
Romania · Delayed Price · Currency is RON 0.7900
-0.0060 (-0.75%)
At close: Jun 11, 2026
Farmaceutica REMEDIA Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 739.02 | 759.76 | 743.79 | 593.36 | 535.85 | 477.1 |
Other Revenue | 1 | 0.98 | 3.23 | - | - | - |
| 740.02 | 760.74 | 747.02 | 593.36 | 535.85 | 477.1 | |
Revenue Growth (YoY) | -3.08% | 1.84% | 25.90% | 10.73% | 12.31% | 8.07% |
Cost of Revenue | 702.73 | 720.41 | 705.14 | 558.54 | 500.19 | 447.83 |
Gross Profit | 37.29 | 40.33 | 41.88 | 34.82 | 35.66 | 29.27 |
Selling, General & Admin | 25.61 | 24.75 | 25.36 | 20.62 | 22.13 | 19.47 |
Amortization of Goodwill & Intangibles | 2.47 | 2.41 | 2.63 | 5.06 | 4.02 | - |
Other Operating Expenses | -1.25 | -0.59 | 0.79 | 2.38 | 3.08 | 0.32 |
Operating Expenses | 26.83 | 26.56 | 28.78 | 28.06 | 29.23 | 21 |
Operating Income | 10.46 | 13.77 | 13.1 | 6.76 | 6.43 | 8.28 |
Interest Expense | -0.05 | -0.05 | -0.1 | -0.12 | -0.16 | -0.11 |
Interest & Investment Income | 1.37 | 1.33 | 1.25 | 0.94 | 0.47 | 0.16 |
Earnings From Equity Investments | 0.3 | 0.25 | -0.11 | -0.28 | - | - |
Currency Exchange Gain (Loss) | -0.27 | -0.34 | -0.16 | -0.04 | -0.08 | -0.06 |
Other Non Operating Income (Expenses) | 0.31 | 0.35 | 0.11 | 0.35 | 0.13 | -0.14 |
EBT Excluding Unusual Items | 12.13 | 15.31 | 14.09 | 7.6 | 6.79 | 8.13 |
Gain (Loss) on Sale of Assets | 0.9 | 0.9 | - | 1.31 | 0.27 | 0.51 |
Pretax Income | 13.03 | 16.21 | 14.09 | 8.91 | 7.06 | 8.63 |
Income Tax Expense | 7.14 | 8.17 | 7.13 | 1.71 | 1.25 | 1.4 |
Net Income | 5.89 | 8.04 | 6.96 | 7.2 | 5.81 | 7.23 |
Net Income to Common | 5.89 | 8.04 | 6.96 | 7.2 | 5.81 | 7.23 |
Net Income Growth | -30.84% | 15.45% | -3.33% | 23.97% | -19.69% | -80.85% |
Shares Outstanding (Basic) | 96 | 95 | 96 | 96 | 96 | 95 |
Shares Outstanding (Diluted) | 96 | 95 | 96 | 96 | 96 | 95 |
Shares Change (YoY) | -0.09% | -0.04% | -0.01% | -0.03% | 0.13% | -10.06% |
EPS (Basic) | 0.06 | 0.08 | 0.07 | 0.08 | 0.06 | 0.08 |
EPS (Diluted) | 0.06 | 0.08 | 0.07 | 0.08 | 0.06 | 0.08 |
EPS Growth | -30.78% | 15.50% | -3.32% | 24.01% | -19.79% | -78.71% |
Free Cash Flow | 5.25 | 14.22 | 17.17 | 21.84 | -2.03 | 2.59 |
Free Cash Flow Per Share | 0.06 | 0.15 | 0.18 | 0.23 | -0.02 | 0.03 |
Dividend Per Share | 0.050 | 0.050 | 0.040 | 0.050 | 0.050 | 0.050 |
Dividend Growth | 25.00% | 25.00% | -20.00% | - | - | -66.67% |
Gross Margin | 5.04% | 5.30% | 5.61% | 5.87% | 6.65% | 6.14% |
Operating Margin | 1.41% | 1.81% | 1.75% | 1.14% | 1.20% | 1.74% |
Profit Margin | 0.80% | 1.06% | 0.93% | 1.21% | 1.08% | 1.52% |
Free Cash Flow Margin | 0.71% | 1.87% | 2.30% | 3.68% | -0.38% | 0.54% |
EBITDA | 12.57 | 15.82 | 15.73 | 10.89 | 10.45 | 9.14 |
EBITDA Margin | 1.70% | 2.08% | 2.10% | 1.84% | 1.95% | 1.92% |
D&A For EBITDA | 2.11 | 2.05 | 2.63 | 4.12 | 4.02 | 0.86 |
EBIT | 10.46 | 13.77 | 13.1 | 6.76 | 6.43 | 8.28 |
EBIT Margin | 1.41% | 1.81% | 1.75% | 1.14% | 1.20% | 1.74% |
Effective Tax Rate | 54.80% | 50.42% | 50.60% | 19.16% | 17.69% | 16.22% |
Revenue as Reported | 742.83 | 763.55 | 747.02 | 598.28 | 539.2 | 477.95 |
Advertising Expenses | - | 0.05 | 0.18 | 0.12 | 0.05 | 0.04 |